Optimal duration and planning of switching treatments taking drug toxicity into account

a convex optimisation approach

Conference Paper (2019)
Author(s)

Carlos Andres Devia (TU Delft - Team Tamas Keviczky)

G. Giordano (TU Delft - Team Tamas Keviczky)

Research Group
Team Tamas Keviczky
Copyright
© 2019 C.A. Devia Pinzon, G. Giordano
DOI related publication
https://doi.org/10.1109/CDC40024.2019.9028881
More Info
expand_more
Publication Year
2019
Language
English
Copyright
© 2019 C.A. Devia Pinzon, G. Giordano
Research Group
Team Tamas Keviczky
Pages (from-to)
5674-5679
ISBN (print)
978-1-7281-1398-2
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

We consider a multi-compartment evolutionary model representing growth, mutation and migration of cancer cells, as well as the effect of drugs, and we design optimal switching targeted cancer therapies where a single drug, or suitable drug combination, is given at each time so as to minimise not only the overall tumor size over a finite horizon, but also drug-provoked side effects. The strong diagonally- dominant structure of the model allows to solve the problem via convex optimisation. We provide an algorithm that yields optimality throughout the whole treatment duration by solving the convex optimisation problem with different horizons, and show how dwell time can be enforced via heuristics. Also the optimal treatment duration can be computed via convex optimisation. The proposed approaches are applied to a model of ALK-rearranged lung carcinoma.

Files

AAM.pdf
(pdf | 0.822 Mb)
License info not available